SARS-CoV-2 (2019-nCoV) and Influenza A/B Virus Combined Nucleic Acid Detection Kit (Fluorescent PCR

CLIA-waived PCR detection kit for simultaneous identification of SARS-CoV-2 and Influenza A/B using direct fluorescence technology. Enables rapid respiratory pathogen screening in clinical and point-of-care settings with streamlined sample-to-result workflow.

Multiplex real-time PCR kit for simultaneous detection and differentiation of SARS-CoV-2, Influenza A, and Influenza B RNA. Intended for laboratory-trained personnel using nasopharyngeal, oropharyngeal, or sputum specimens.

Multiplex PCR test kit for simultaneous detection of COVID-19, Influenza A, and Influenza B nucleic acids. Designed for rapid respiratory pathogen identification in clinical and laboratory settings. Delivers high sensitivity and specificity for differential diagnosis of acute respiratory infections.

SARS-CoV-2 Nucleic Acid Detection Kit using fluorescent PCR method for rapid and accurate identification of COVID-19 infection. The kit enables qualitative detection of viral RNA in respiratory specimens, supporting clinical diagnosis and epidemiological surveillance. Designed for laboratory use with high sensitivity and specificity.

PCR-based nucleic acid detection kit for COVID-19 diagnosis using fluorescent probe technology. Designed for rapid and accurate identification of SARS-CoV-2 in clinical respiratory samples. Enables quantitative and qualitative analysis in laboratory and point-of-care settings.

Multiplex real-time PCR assay for simultaneous detection of SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus. Facilitates rapid differential diagnosis of respiratory viral infections.

Fluorescence PCR-based detection kit for rapid identification of Influenza A and B viruses in clinical specimens. Designed for molecular diagnostics in laboratory settings with high sensitivity and specificity for influenza virus screening and confirmation.

This diagnostic kit detects SARS-CoV-2 (COVID-19), Influenza A Virus, Influenza B Virus, and Respiratory Syncytial Virus using PCR-fluorescence technology. Influenza A viruses are most likely to cause epidemic outbreaks due to proneness to genetic mutations, increasing infectivity and pathogenicity, often causing worldwide periodic epidemics. Influenza B viruses often cause local outbreaks. Respiratory syncytial virus is the most common and important pathogen of lower respiratory tract infections in infants and young children, easily causing bronchiolitis and pneumonia with serious complications.

Multiplex real-time PCR assay enabling simultaneous detection of SARS-CoV-2, Influenza A, and Influenza B from a single sample. This molecular diagnostic test provides efficient multi-pathogen screening in clinical settings.

This kit is used for auxiliary diagnosis of influenza diseases caused by both influenza A and B viruses.

Multiplex RT-PCR kit for detection of major respiratory viral infections including SARS-CoV-2, influenza, and respiratory syncytial virus. This test enables simultaneous identification of multiple clinically significant respiratory viruses.

CLIA-waived fluorescence PCR detection kit for rapid SARS-CoV-2 identification. The AccuFluor platform delivers real-time PCR results for COVID-19 diagnosis with 510(k) clearance, enabling healthcare facilities to quickly screen patients and guide clinical management decisions.